Drug
Sfericase clinical trials
Also written AL-794.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How studies write it
Studies that test it under each name
Development codes
- AL-794
- 3
Studies by the year they started
4 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses sfericase is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872CompletedPhase 1Alios Biopharma Inc.NCT02888327Written as AL-794
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy VolunteersTerminatedPhase 1Alios Biopharma Inc.NCT03411421Written as AL-794
- A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge StudyCompletedPhase 1Alios Biopharma Inc.NCT02588521Written as AL-794
- A Study to Assess the PK of AL-794 Formulations in Healthy SubjectsCompletedPhase 1Alios Biopharma Inc.NCT02877160Written as AL-794 suspension